review Open AccessTop 1% cited
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
The American Journal of Human Genetics · 2003 · Vol. 72(5) · pp. 1117–1130
Antonis C. Antoniou(Cancer Research UK)Paul D.P. Pharoah✉(University of Cambridge)Steven A. Narod(University of Toronto)Harvey A. Risch(Yale University)J.E. Eyfjörd(University of Iceland)John L. Hopper(University of Melbourne)Niklas Loman(Lund University)Håkan Olsson(Lund University)Oskar T. Johannsson(Lund University)Åke Borg(Lund University)Barbara PasiniPaolo Radice(FIRC Institute of Molecular Oncology)Siranoush ManoukianDiana Eccles(Princess Anne Hospital)Nelson L.S. Tang(Chinese University of Hong Kong)Edith Oláh(National Institute of Oncology)Hoda Anton‐Culver(University of California, Irvine)Ellen Warner(University of Toronto)Jan Lubiński(International Hereditary Cancer Center)Jacek Gronwald(International Hereditary Cancer Center)Bohdan Górski(International Hereditary Cancer Center)Hrafn Tulinius(University of Iceland)Steinunn Thorlacius(University of Iceland)Hannaleena Eerola(Helsinki University Hospital)Heli NevanlinnaKirsi Syrjäkoski(Tampere University)Olli Kallioniemi(Tampere University Hospital)Deborah J. Thompson(Cancer Research UK)Chris Evans(Cancer Research UK)Julian Peto(Institute of Cancer Research)Fiona Lalloo(St. Mary's Hospital)D. Gareth Evans(St. Mary's Hospital)Douglas F. Easton(Cancer Research UK)
BRCA gene mutations in cancerCancer Genomics and DiagnosticsOvarian cancer diagnosis and treatmentBreast cancerOvarian cancerFamily historyMedicineGermline mutationOncologyCancerContext (archaeology)Relative riskInternal medicine
MeSH terms
AdultAgedBreast NeoplasmsFamilyFemaleGenetic TestingHeterozygoteHumansMaleMiddle AgedMutationOvarian NeoplasmsPedigreeRiskGlobal Health
Citations
3,661
FWCI
63.41
field-weighted impact
References
57
Percentile
100%
vs. same field & year
Citations per year
Cited by
Evaluation of adnexal mass in reproductive and perimenopausal age group
International Journal of Clinical Obstetrics and Gynaecology · 2021 · 3 citations
The Landscape of Targeted Therapies in TNBC
Cancers · 2020 · 434 citations
Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers
Gynecologic Oncology · 2005 · 375 citations
The personal and clinical utility of polygenic risk scores
Nature Reviews Genetics · 2018 · 1,681 citations
Comprehensive statistical study of 452 BRCA1 missense substitutions with classification of eight recurrent substitutions as neutral
Journal of Medical Genetics · 2005 · 660 citations
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Annals of Oncology · 2010 · 2,860 citations
American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography
CA A Cancer Journal for Clinicians · 2007 · 2,644 citations
Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Annals of Oncology · 2015 · 1,618 citations
References
Prevalence and Penetrance of Germline BRCA1 and BRCA2 Mutations in a Population Series of 649 Women with Ovarian Cancer
The American Journal of Human Genetics · 2001 · 992 citations
Genetic Heterogeneity and Penetrance Analysis of the BRCA1 and BRCA2 Genes in Breast Cancer Families
The American Journal of Human Genetics · 1998 · 3,035 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.